MedTrace Logo

Coenzyme Q10 in Older Athletes Treated With Statin Medications

NCT01026311 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-05-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of coenzyme Q10 administration in improving mitochondrial function as measured by anaerobic threshold in older athletes on a stable dose of statin medication.

Conditions

  • Muscle Weakness
  • Myalgia
  • Side Effects of Statins

Interventions

DRUG

Coenzyme q 10

200 mg of Coenzyme q 10

DRUG

placebo

1 placebo q d during treatment period

Sponsors & Collaborators

  • Richard Deichmann, MD

    lead OTHER

Principal Investigators

  • Richard Deichmann, MD · Ochsner

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01026311 on ClinicalTrials.gov